This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Europe's premier partnering event
November 4–6, 2024 | Stockholm, SwedenNovember 12–13, 2024 | Digital Partnering

HemostOD SA


HemostOD is a preclinical stage company developing a therapeutic platform inspired by platelet biology, allowing: - The production of in-vitro platelets as an alternative to unsatisfactory blood donor platelet transfusions - The production of HLA-null platelet to treat and prevent immune refractoriness in patients facing hypo proliferative thrombocytopenia - The production of siRNA/protein delivery solutions, exploiting natural platelets skills